TrovaGene Stikes A Preferred Provider Deal With Stratose

Loading...
Loading...
TrovaGene Inc
TROV
said that it struck a deal with Stratose, Inc. creating in-network health plan access to its suite of Precision Cancer Monitoring tests, as well as, services. According to the company, Stratose maintained its position of one of the biggest directly managed PPO networks in the America. That helped to administer health benefits for over 8.6 million covered lives. TrovaGene's Chief Commercial Officer, Matt Posard, said, "We are pleased that Stratose has included us as a preferred provider in their healthcare delivery network.' He added, "We continue to execute on our strategy to commercialize our novel liquid biopsy platform and to improve the care of cancer patients with our non-invasive tests for the detection and monitoring of medically relevant oncogene mutations." On Friday, the stock slipped 2.53%.
Posted In: NewsSmall CapPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...